OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2023
(3)
2024
(2)
2016
(1)
2014
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer.
Not available
S-EPMC11094424
|
biostudies-literature
Cite
Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Not available
S-EPMC3927731
|
biostudies-literature
Cite
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.
Not available
S-EPMC11609621
|
biostudies-literature
Cite
Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
Not available
S-EPMC5011450
|
biostudies-literature
Cite
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Not available
S-EPMC10461952
|
biostudies-literature
Cite
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Not available
S-EPMC9839304
|
biostudies-literature
Cite
Tropical Data: Approach and Methodology as Applied to Trachoma Prevalence Surveys.
Not available
S-EPMC10751062
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets